Antiviral activity and safety of TMC435 combined with peginterferon ALPHA-2A and ribavirin in patients with genotype 1 hepatitis C infection who failed previous IFN-Based therapy

Authors
Category Primary study
JournalJournal of Hepatology
Year 2009
This article has no abstract
Epistemonikos ID: c4a77a7e82cd0595a385d09feb1479637ccf27a9
First added on: Feb 28, 2025